KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 112 filers reported holding KEROS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,335,221 | +129.0% | 58,119 | +143.4% | 0.05% | +80.0% |
| Q1 2023 | $1,019,676 | -9.6% | 23,880 | +1.7% | 0.03% | -6.2% |
| Q4 2022 | $1,127,990 | +27.6% | 23,490 | -0.1% | 0.03% | +23.1% |
| Q3 2022 | $884,000 | -32.2% | 23,506 | -50.2% | 0.03% | -29.7% |
| Q2 2022 | $1,304,000 | -48.3% | 47,182 | +1.8% | 0.04% | -38.3% |
| Q1 2022 | $2,520,000 | -7.8% | 46,338 | -0.8% | 0.06% | +3.4% |
| Q4 2021 | $2,733,000 | +57.8% | 46,705 | +6.7% | 0.06% | +48.7% |
| Q3 2021 | $1,732,000 | -8.3% | 43,787 | -1.5% | 0.04% | -4.9% |
| Q2 2021 | $1,888,000 | -54.9% | 44,466 | -34.6% | 0.04% | -51.2% |
| Q1 2021 | $4,184,000 | – | 67,980 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |